Clinical Trial Update: Vitamin C to Reduce Vasopressor Dose in Septic Shock [Phase 3]

View source ↗

Summary

Phase 3 trial investigating vitamin C to reduce vasopressor dose in septic shock has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Vitamin C (ascorbic acid)

Snippet

Sponsor: Hospital Español de Mexico | Conditions: Septic Shock, Sepsis | Phase 3 | Status: WITHDRAWN